Alvotech's (NASDAQ:ALVO) largest shareholders are private equity firms with 34% ownership, private companies own 31%

In This Article:

Key Insights

  • Alvotech's significant private equity firms ownership suggests that the key decisions are influenced by shareholders from the larger public

  • 63% of the business is held by the top 2 shareholders

  • Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock

A look at the shareholders of Alvotech (NASDAQ:ALVO) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are private equity firms with 34% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

Private companies, on the other hand, account for 31% of the company's stockholders.

Let's take a closer look to see what the different types of shareholders can tell us about Alvotech.

View our latest analysis for Alvotech

ownership-breakdown
NasdaqGM:ALVO Ownership Breakdown January 26th 2025

What Does The Institutional Ownership Tell Us About Alvotech?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

Alvotech already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Alvotech's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
NasdaqGM:ALVO Earnings and Revenue Growth January 26th 2025

We note that hedge funds don't have a meaningful investment in Alvotech. The company's largest shareholder is Aztiq Pharma Partners S.à R.L., with ownership of 34%. For context, the second largest shareholder holds about 30% of the shares outstanding, followed by an ownership of 1.1% by the third-largest shareholder.

After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.